| Literature DB >> 28811636 |
Ying Liu1, Guoqiang Zhou2, Zhu Liu1,2, Mengyu Guo1, Xiumei Jiang1, Mehmet Berat Taskin3, Zhongyang Zhang3, Jing Liu1, Jinglong Tang1, Ru Bai1, Flemming Besenbacher3, Menglin Chen4, Chunying Chen5.
Abstract
Electrospun scaffolds with excellent mechanical properties, high specific surface area and a commendable porous network are widely used in tissue engineering. Improving the hydrophilicity and cell adhesion of hydrophobic substrates is the key point to enhance the effectiveness of electrospun scaffolds. In this study, polycaprolactone (PCL) fibrous membranes with appropriate diameter were selected and coated by mussel-inspired poly norepinephrine (pNE). And norepinephrine is a catecholamine functioning as a hormone and neurotransmitter in the human brain. The membrane with smaller diameter fibers, a relative larger specific surface area and the suitable pNE functionalization provided more suitable microenvironment for cell adhesion and proliferation both in vitro and in vivo. The regenerated muscle layer can be integrated well with fibrous membranes and surrounding tissues at the impaired site and thus the mechanical strength reached the value of native tissue. The underlying molecular mechanism is mediated via inhibiting myostatin expression by PI3K/AKT/mTOR hypertrophy pathway. The properly functionalized fibrous membranes hold the potential for repairing muscle injuries. Our current work also provides an insight for rational design and development of better tissue engineering materials for skeletal muscle regeneration.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28811636 PMCID: PMC5557809 DOI: 10.1038/s41598-017-08572-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Scheme of pNE coated PCL electrospun fibrous membranes and their effect on muscle regeneration in vitro and in vivo.
Figure 2Characterization of PCL fibrous membranes. (A–D) XPS spectra (a,e,i,m), SEM (b,c,f,g,j,k,n,o) and AFM images (d,h,l,p). A, PCL fibrous membrane with 2 μm in diameter (2 P). B, pNE coated PCL fibrous membrane with 2 μm in diameter (2 PP). C, PCL fibrous membrane with 10 μm in diameter (10 P). D, pNE coated PCL fibrous membrane with 10 μm in diameter (10 PP). (E-H) The mechanical property, wettability and degradation in vitro of PCL fibrous membranes. E, The stress-strain curves of PCL fibrous membranes. F, Images and quantitative statistics of contact angle. G, Mass loss of PCL fibrous membranes after cultured in PBS at 37 °C for 11, 33, 66 and 99 days, respectively. H, SEM images of PCL fibrous membranes after cultured in PBS at 37 °C for 11, 33, 66 and 99 days.
Elemental composition of fibrous membrane surfaces.
| Elements | C (%) | O (%) | N (%) | N/C (%) |
|---|---|---|---|---|
| 2 P | 78.886 | 21.114 | 0 | 0 |
| 2 PP | 74.384 | 21.252 | 4.364 | 5.87 |
| 10 P | 80.923 | 19.077 | 0 | 0 |
| 10 PP | 75.111 | 22.68 | 2.21 | 2.94 |
Figure 3Functionalized electrospun PCL memberanes were effective for the regenerating muscle injury. (A) Diagram of PCL fibrous membranes implantation in vivo. After implantation into rat muscles for 40 days, mechanical properties of PCL fibrous membranes (B), visible morphology (C) and histological observations (D) of muscles and SEM images of PCL fibrous membranes (E) were observed.
Figure 4Thinner functionalized electrospun PCL microfibers (2 PP) were more effective for the muscle cell proliferation and adhesion. (A) After cultured on PCL fibrous membranes for 1, 3, 5 and 7 days, cell proliferation was detected using CCK-8. (B) ESEM and fluorescent images of cells on PCL fibrous membranes.
Figure 5Thinner functionalized electrospun PCL microfibers (2 PP) were more effective for the muscle cell growth and differentiation. (A,B) Relative expression of IGF1, PI3K, AKT, mTOR and myostatin of cells and muscle tissues. C, Representative western blotting of PI3K, AKT and myostatin of muscle tissues from in vivo experiments. *, #, $ p < 0.05 and **p < 0.01 as indicated.
| forward | reverse | |
|---|---|---|
| IGF1 | 5′-CAGCATCGTGTGGCAGGAC-3′ | 5′-TCTTGGTCAGGTGGCGTAA-3′ |
| PI3K | 5′-AGGCTGTGATTGGGCGTA -3′ | 5′-AAGCAACCTCAAAGGGAAA-3′ |
| AKT | 5′-CTTGACATGAACCCAGGCAC-3′ | 5′-TTCAGCCCATCTTCTCCTGG-3′ |
| mTOR | 5′-GACGGTGTAGAACTTGGAGAA-3′ | 5′-TGAGATGTCGCTTGCTTGA-3′ |
| Myostain | 5′-CTACCACGGAAACAATCA TTA-3′ | 5′-AGCAACATTTGGGCTTTCCAT-3′ |
| GAPDH | 5′-AACTTTGGCATTGTGGAAGG -3′ | 5′-ACACATTGGGGGTAGGAACA-3′ |